Laura Safar, MD, on Neuropsychiatric Disorders Among Patients With Multiple Sclerosis: Psychotropic Treatment Classes and Options

In this video, Laura T. Safar, MD, gives an overview of psychotropic treatment classes, their uses in the management of neuropsychiatric disorders among patients with multiple sclerosis, and important considerations for each class. She recently gave a talk on this topic at the Consortium for Multiple Sclerosis Centers Virtual Meeting.

Reference:

• Safar LT. Use of psychotropics in MS: antidepressants, antianxiety agents, mood stabilizers, hypnotics, antipsychotics, and cognitive enhancers. Talk presented at: Consortium of Multiple Sclerosis Centers 2020 Virtual Meeting; May 28, 2020.

Laura T. Safar, MD, is an assistant professor of psychiatry at Harvard Medical School, and vice chair of psychiatry at Lahey Hospital & Medical Center in Massachusetts.